SCHEMBL10032016

SCHEMBL10032016

O=C(NC(Nc1ccc(Cl)c(F)c1)C(F)(F)C(F)(F)F)c1cc(Br)co1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 4/20 0.42
S1PR1 P21453 3/20 0.42
S1PR4 O95977 2/20 0.42
BACE1 P56817 1/20 0.35
AR P10275 2/20 0.35
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
ALDH1A1 P00352 2/20 0.34
ALOX12 P18054 1/20 0.34
MAOB P27338 1/20 0.34
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
HTT P42858 2/20 0.32
KCNQ3 O43525 2/20 0.32
KCNQ2 O43526 2/20 0.32
KCNE1 P15382 2/20 0.32
KCNQ1 P51787 2/20 0.32
KCNQ5 Q9NR82 1/20 0.32
MMP8 P22894 1/20 0.32
MMP14 P50281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10032031 0.88 POLB (0.39) S1PR3S1PR1S1PR4BACE1MAPT
SCHEMBL1243994 0.79 S1PR3 (0.40) S1PR3S1PR1S1PR4BACE1KCNQ3
SCHEMBL1922852 0.74 MEN1 (0.47) S1PR3S1PR1S1PR4MAPTNPSR1
SCHEMBL1164079 0.73 S1PR3 (0.38) S1PR3S1PR1S1PR4BACE1KCNQ3
SCHEMBL1923694 0.72 ALDH1A1 (0.61) MAPTNPSR1ALDH1A1ALOX12KMT2A
SCHEMBL1923171 0.71 MAPT (0.51) S1PR3S1PR1ARMAPTNPSR1
SCHEMBL12156721 0.71 MEN1 (0.53) S1PR3S1PR1S1PR4MAPTNPSR1
SCHEMBL1164008 0.67 TRPA1 (0.49) MAPTNPSR1ALDH1A1KMT2AMEN1
SCHEMBL1163988 0.65 HTT (0.42) S1PR3S1PR1ARMAPTNPSR1
SCHEMBL1164430 0.64 NPC1 (0.43) S1PR3S1PR1BACE1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120190694-A1 SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS ALLERGAN, INC. (US) 2012-07-26 US disclosed
US-8168795-B2 Selective sphingosine-1-phosphate receptor antagonists ALLERGAN, INC. (US) 2012-05-01 US disclosed
US-20110039866-A1 SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS ALLERGAN, INC. (US) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190694-A1 SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS S1PR3, S1PR1, S1PR2 S1PR3 1/4885S1PR1 2/4885S1PR4 4/4885
US-20110039866-A1 SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS S1PR3, S1PR1, S1PR2 S1PR3 1/4885S1PR1 2/4885S1PR4 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.